AzTrials
AzTrials

Computer AssistedNCT07575022

Computer Assisted Navigation on Endoscopic Sinus Surgery for Treatment of Sinonasal Polyposis

An observational study of Computer Assisted and Navigation, run by Al-Azhar University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to compare Endoscopic Sinus Surgery with and without image guidance, analyzing a number of parameters that can impact efficacy in cases of nasal polyposis. Read more about this study

Who is it for?
Ages 15 to 70 years
What is being tested?
Endoscopic sinus surgery with Computer Assisted Navigation and Endoscopic sinus surgery
Type of treatment
Surgery or procedure
How many people
40 participants
Where
1 siteEgypt
Study dates
1 Jun 2023to 1 Jun 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 70 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: This Prospective comparative study was carried out on 40 patients aged from above 15 and below 70 years old, both sexes, with nasal polyposis undergoing ESS whether primary or revision cases. The study was done after approval from the Ethical Committee Al Azhar University, Cairo, Egypt.

Who may be able to join

  • Age from 15 to 70 years.
  • Both sex.
  • Patients with nasal polyposis undergoing endoscopic sinus surgery (ESS) whether primary or revision cases.

Who cannot join

  • Patients with nasal polyposis not undergoing ESS.
  • Patients with any severe cardiac diseases, pregnant females, transplant patients and patients with psychiatric illness.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Al-Azhar University

    Cairo, 11651

Other trials in Egypt

About this study

Official title: Impact of Computer Assisted Navigation on Endoscopic Sinus Surgery for Treatment of Sinonasal Polyposis

This study aimed to compare Endoscopic Sinus Surgery with and without image guidance, analyzing a number of parameters that can impact efficacy in cases of nasal polyposis.

Read the detailed description

Endoscopic sinus surgery (ESS) is a treatment of choice for rhinosinusitis (CRS), sinonasal polyposis and in cases of skull base diseases. Despite the availability of excellent nasal telescopes and high-resolution preoperative computed tomography (CT), incidence of complications in endoscopic sinus surgery is of 0-1.5% for the major and 1.1-20.8% for the minor.

Electromagnetic and optical localization systems both enable real-time detection of instrument position in a 3D imaging repository. At present, such repositories are exclusively based on CT acquisitions reformatted to obtain a series of slices in three dimensions. A software interface matches the imaging repository to a peroperative spatial repository in which the instrument can be located.

Being tested
Endoscopic sinus surgery with Computer Assisted Navigation, Endoscopic sinus surgery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endoscopic sinus surgery with Computer Assisted NavigationProcedure or surgery

    Patients with nasal polyposis undergoing endoscopic sinus surgery with Computer Assisted Navigation.

  • Endoscopic sinus surgeryProcedure or surgery

    Patients with nasal polyposis undergoing endoscopic sinus surgery only.

Study groups in NCT07575022
Study groupRoleWhat they receive
Group IPatients with nasal polyposis undergoing endoscopic sinus surgery with Computer Assisted Navigation.
Receives: Procedure: Endoscopic sinus surgery with Computer Assisted Navigation
Group IIPatients with nasal polyposis undergoing endoscopic sinus surgery only.
Receives: Procedure: Endoscopic sinus surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recurrence rate

    Recurrence rate was recorded.

    Measured: 3 months after the procedure

Secondary outcomes (2)
  1. Incidence of major complications

    Incidence of major complications like cerebrospinal fluid (CSF) leakage, Carotid artery injury, Brain injury, Blindness, Orbital hematoma and persistent diplopia were recorded.

    Measured: 3 months after the procedure

  2. Incidence of minor complications

    Incidence of minor complications like Orbital fat extrusion, Bleeding, Dural exposure, Nasolacrimal duct injury, Synechiae and edema were recorded

    Measured: 3 months after the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2026
  2. Study start1 Jun 2023
  3. Primary completion1 Jun 2024
  4. Study completion1 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07575022
Sponsor's protocol ID
1690
Status last verified
May 2026
First submitted
3 May 2026
Last updated
8 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Questions about this trial

What is this clinical trial studying?

An observational study of Computer Assisted and Navigation, run by Al-Azhar University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recurrence rate (time frame: 3 months after the procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in